Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
BMC Neuroscience
|
August 14, 2016
Hysteretic behavior of bladder afferent neurons in response to changes in bladder pressure
Shani E Ross, Zachariah J Sperry, Colin M Mahar, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
March 24, 2011
Impact of SLCO1B1 (OATP1B1) and ABCG2 (BCRP) genetic polymorphisms and inhibition on LDL-C lowering and myopathy of statins
Grant T Generaux, Fiorenza M Bonomo, Marta Johnson, et al.
Clinical Pharmacology in Drug Development
|
February 6, 2019
Randomized Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Topical Daprodustat in Healthy Volunteers and in Patients With Diabetic Foot Ulcers
Eric Olson, Kelly M Mahar, Lisa Morgan, et al.
Clinical Pharmacology in Drug Development
|
May 31, 2017
Single- and Multiple-Day Dosing Studies to Investigate High-Dose Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers
Kelly M Mahar, Mary Beth Enslin, Angie Gress, et al.
Clinical Pharmacokinetics
|
September 11, 2024
Integrated Population Pharmacokinetics of Daprodustat in Patients with Chronic Kidney Disease with Anemia
Kelly M Mahar, Shuying Yang, Emir Mesic, et al.
Pharmaceutical Research
|
July 7, 2007
Gastric pH and gastric residence time in fasted and fed conscious cynomolgus monkeys using the Bravo pH system
Emile P Chen, Kelly M Mahar Doan, Samm Portelli, et al.
Clinical Pharmacology in Drug Development
|
May 1, 2023
Comparison of Two Manufacturing Processes of Daprodustat for Bioequivalence and Dissolution in Healthy Volunteers: A Randomized Crossover Study
Bonnie Shaddinger, Kelly M Mahar, Mike Sprys, et al.
BMC Nephrology
|
October 18, 2019
A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis
Christine K Bailey, Stephen Caltabiano, Alexander R Cobitz, et al.
Pharmacology Research & Perspectives
|
March 17, 2018
The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects
Stephen Caltabiano, Kelly M Mahar, Karyn Lister, et al.
Clinical Pharmacology in Drug Development
|
April 7, 2020
A Single-Dose, Open-Label, Randomized, Two-Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat
Masanori Yamada, Minori Osamura, Hirofumi Ogura, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
BMC Neuroscience
|
August 14, 2016
Hysteretic behavior of bladder afferent neurons in response to changes in bladder pressure
Shani E Ross, Zachariah J Sperry, Colin M Mahar, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
March 24, 2011
Impact of SLCO1B1 (OATP1B1) and ABCG2 (BCRP) genetic polymorphisms and inhibition on LDL-C lowering and myopathy of statins
Grant T Generaux, Fiorenza M Bonomo, Marta Johnson, et al.
Clinical Pharmacology in Drug Development
|
February 6, 2019
Randomized Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Topical Daprodustat in Healthy Volunteers and in Patients With Diabetic Foot Ulcers
Eric Olson, Kelly M Mahar, Lisa Morgan, et al.
Clinical Pharmacology in Drug Development
|
May 31, 2017
Single- and Multiple-Day Dosing Studies to Investigate High-Dose Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers
Kelly M Mahar, Mary Beth Enslin, Angie Gress, et al.
Clinical Pharmacokinetics
|
September 11, 2024
Integrated Population Pharmacokinetics of Daprodustat in Patients with Chronic Kidney Disease with Anemia
Kelly M Mahar, Shuying Yang, Emir Mesic, et al.
Pharmaceutical Research
|
July 7, 2007
Gastric pH and gastric residence time in fasted and fed conscious cynomolgus monkeys using the Bravo pH system
Emile P Chen, Kelly M Mahar Doan, Samm Portelli, et al.
Clinical Pharmacology in Drug Development
|
May 1, 2023
Comparison of Two Manufacturing Processes of Daprodustat for Bioequivalence and Dissolution in Healthy Volunteers: A Randomized Crossover Study
Bonnie Shaddinger, Kelly M Mahar, Mike Sprys, et al.
BMC Nephrology
|
October 18, 2019
A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis
Christine K Bailey, Stephen Caltabiano, Alexander R Cobitz, et al.
Pharmacology Research & Perspectives
|
March 17, 2018
The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects
Stephen Caltabiano, Kelly M Mahar, Karyn Lister, et al.
Clinical Pharmacology in Drug Development
|
April 7, 2020
A Single-Dose, Open-Label, Randomized, Two-Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat
Masanori Yamada, Minori Osamura, Hirofumi Ogura, et al.
Page
of 5